[HTML][HTML] Dengue overview: An updated systemic review

MB Khan, ZS Yang, CY Lin, MC Hsu, AN Urbina… - Journal of infection and …, 2023‏ - Elsevier
Dengue is caused by the dengue virus (DENVs) infection and clinical manifestations include
dengue fever (DF), dengue hemorrhagic fever (DHF), or dengue shock syndrome (DSS) …

Dengue

G Paz-Bailey, LE Adams, J Deen, KB Anderson… - The Lancet, 2024‏ - thelancet.com
Dengue, caused by four closely related viruses, is a growing global public health concern,
with outbreaks capable of overwhelming health-care systems and disrupting economies …

Live, attenuated, tetravalent Butantan–dengue vaccine in children and adults

EG Kallás, MAT Cintra, JA Moreira… - … England Journal of …, 2024‏ - Mass Medical Soc
Abstract Background Butantan–Dengue Vaccine (Butantan-DV) is an investigational, single-
dose, live, attenuated, tetravalent vaccine against dengue disease, but data on its overall …

[HTML][HTML] Dengue virus infection–a review of pathogenesis, vaccines, diagnosis and therapy

BH Kok, HT Lim, CP Lim, NS Lai, CY Leow, CH Leow - Virus research, 2023‏ - Elsevier
The transmission of dengue virus (DENV) from an infected Aedes mosquito to a human,
causes illness ranging from mild dengue fever to fatal dengue shock syndrome. The similar …

[HTML][HTML] Nutritional Profile and Health Benefits of Ganoderma lucidum “Lingzhi, Reishi, or Mannentake” as Functional Foods: Current Scenario and Future …

AF El Sheikha - Foods, 2022‏ - mdpi.com
Ganoderma lucidum has a long history of medicinal uses in the Far East countries of more
than 2000 years due to its healing properties. Recently, G. lucidum has come under …

[HTML][HTML] Dengue: a minireview

H Harapan, A Michie, RT Sasmono, A Imrie - Viruses, 2020‏ - mdpi.com
Dengue, caused by infection of any of four dengue virus serotypes (DENV-1 to DENV-4), is a
mosquito-borne disease of major public health concern associated with significant morbidity …

A perspective on potential antibody-dependent enhancement of SARS-CoV-2

AM Arvin, K Fink, MA Schmid, A Cathcart, R Spreafico… - Nature, 2020‏ - nature.com
Antibody-dependent enhancement (ADE) of disease is a general concern for the
development of vaccines and antibody therapies because the mechanisms that underlie …

Efficacy of Wolbachia-infected mosquito deployments for the control of dengue

A Utarini, C Indriani, RA Ahmad… - … England Journal of …, 2021‏ - Mass Medical Soc
Background Aedes aegypti mosquitoes infected with the w Mel strain of Wolbachia pipientis
are less susceptible than wild-type A. aegypti to dengue virus infection. Methods We …

[HTML][HTML] Dengue: a growing problem with new interventions

JM Wong, LE Adams, AP Durbin, JL Muñoz-Jordán… - …, 2022‏ - publications.aap.org
Dengue is the disease caused by 1 of 4 distinct, but closely related dengue viruses (DENV-1–
4) that are transmitted by Aedes spp. mosquito vectors. It is the most common arboviral …

Dengue

A Wilder-Smith, EE Ooi, O Horstick, B Wills - The Lancet, 2019‏ - thelancet.com
Mortality from severe dengue is low, but the economic and resource burden on health
services remains substantial in endemic settings. Unfortunately, progress towards …